Dementia Resilience With Jill Lorentz

October 4, 2022 My guest today is Dr. Peter Pressman, Neurologist and Researcher at the University of Colorado Hospital Anschutz in Denver, Colorado. Dr Pressman and Dr. Huntington Potter are looking for people to join the newest phase of the Sargramostim clinical trial. Otherwise known as the Leukine study. This clinical research is showing promise in fighting Alzheimer's disease. Dr Pressman talks about what the research trial will entail, as well as answering some burning questions about the validity of some research that has drawn attention for not so good reasons. Dr. Pressman gets very candid and answers the tough questions in this segment. Do you have mild-to-moderate Alzheimer’s disease?You may be eligible for a clinical trial for an investigational drug for the treatment ofmild-to-moderate Alzheimer’s disease. Participants will be asked to participate in weeklyvisits for 24 weeks, as well as screening and follow-up visits.In order to qualify you must:• be between 60-80 years old• have a d